Is OPRX or PHR more undervalued in 2026?

CirclFi compares OptimizeRx Corporation (OPRX) and Phreesia, Inc. (PHR) using 13 institutional-grade valuation models. OPRX has a Quality of Company score of 9.3/10 while PHR scores 7.6/10.

Which is a better buy — OPRX or PHR?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do OPRX and PHR valuations compare?

OPRX at $5.10 and PHR at $9.45 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

OPRX vs PHR Valuation Comparison 2026 — Intrinsic Value Analysis

OPRX

Health Information Services

OptimizeRx Corporation

Quality

9.3

out of 10

Value Trap

LOW

Price

$5.10

Last close

Models

12/13

Active

PHR

Health Information Services

Phreesia, Inc.

Quality

7.6

out of 10

Value Trap

LOW

Price

$9.45

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	OPRX Fair Value	OPRX Upside	PHR Fair Value	PHR Upside
Bayesian DCF	Intrinsic	$8.30	+62.8%	$0.45	-95.3%
Earnings Power Value	Intrinsic	$6.98	+36.9%	$2.63	-72.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for OPRX vs PHR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

OPRX vs PHR — Which Stock Is More Undervalued?

OPRX scores higher with a 9.3/10 quality rating vs PHR's 7.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing OptimizeRx Corporation (OPRX) and Phreesia, Inc. (PHR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

OPRX currently trades at $5.10 with a QOC of 9.3/10, while PHR trades at $9.45 with a QOC of 7.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).